“Our People are our greatest strength,” emphasizes Anirban Mitra, Head- HR & Admin, TCG Lifesciences while talking about the Covid Vaccination drive, its relevance, and overall workplace safety.
Molecules to Medicines Webinar: The drug development engine accelerating “Molecules to Medicines”.
In this webinar, Dr. Joseph D. Armstrong, III, COO of TCG GreenChem, Inc. (NJ & VA, USA) addresses how molecules can be accelerated from lead optimization into Phase I clinical trials by leveraging his and his colleagues’, Dr. Chris Senanayake, CEO of TCG GreenChem, Inc., Dr. Robert Wenslow (Co-Founder and VP of Business Development USA/EU of Crystal Pharmatech) and Dr. Yongqiang Li (Co-Founder and CEO of Candoo Pharmatech), decades long experience in expediting molecules through the drug development pipeline.
He describes how utilizing novel technology of Process Research & Development, ( i.e., high throughput experimentation (HTE), catalysis and continuous flow chemistry) with a “First Time Right” strategy, can greatly shorten the time needed to design, development and manufacture the preclinical candidate with the appropriate form, purity and formulation for the enabling toxicity studies and “First in Human” study. This holistic approach in bringing these activities (Process Research, Solid State Characterization, and Formulation Development) together seamlessly, is what allows The Drug Development Engine to “Accelerate Molecules to Medicines”.
Dr. Chris Senanayake sharing his views on the role of private sector companies on cross sector collaboration with the Medicines for All Institute
Dr. Chris Senanayake, CEO & CSO of TCG GreenChem, Inc. (NJ & VA, USA) CSO of TCG Lifesciences Pvt. Ltd. (India) sharing his views on the role of private sector companies on cross sector collaboration with the Medicines for All Institute based at Virginia Commonwealth University (VCU) in Richmond, Virginia, where Dr. Frank Gupton is CEO.
He also talks about how TCG GreenChem, Inc. is working towards meeting the unmet needs of delivering critical medicines for the treatment of HIV, COVID-19, and other diseases and provides these drugs to less developed nations at an affordable cost via green and sustainable manufacturing processes that supports the global environment.
Acceptance Speech by Mr. Swapan Bhattacharya , Managing Director – TCG Lifesciences Pvt. Ltd. on receiving the Biospectrum Excellence Awards 2020 – Innovation in CRO Sector
.jpg ?>)
.jpg ?>)
